Account
News
19.05.2021
PMA Insights Week 23

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
11.02.2021
EMA Human Medicines

Last month, EMA published its overview of key recommendations for 2020 on the authorisation and safe...

Read more
News
09.02.2021
PMA Insights: Week 6

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
04.12.2020
What are the 5 Pricing and Market Access trends th...

Our experts predict the 5 trends they think will dominate the European pricing and market access lan...

Read more
Publications
19.11.2020
COVID-19 impact on HTA bodies

HTA bodies and companies within the pharmaceutical industry have been forced to react to unprecedent...

Read more
Articles
28.10.2020
EMA regulatory decisions after BREXIT

The UK will continue to adopt decisions taken by the European Commission on the approval of new mark...

Read more
Articles
23.10.2020
Sustainable biosimilar marketplaces

To facilitate biosimilar uptake, several mechanisms encouraging biosimilar uptake have been implemen...

Read more
Articles
12.10.2020
What impact has COVID-19 had on HTA bodies

A survey of employees within pricing and market access n pharma and biotech companies.

Read more
Articles
28.07.2020
SMC restarts medicines appraisals process

The SMC has recently announced that it is beginning to restart its medicines appraisal process in a ...

Read more
Articles
23.06.2020
COVID-19 impact on pricing and market access

Without a doubt, the impact of COVID-19 will influence all sectors, including the future of market a...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.